Department of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Department of Forensic Medicine, Hebei North University, Zhangjiakou 075000, China.
Biomolecules. 2022 Dec 14;12(12):1872. doi: 10.3390/biom12121872.
Neurodegeneration can benefit from ischemic preconditioning, a natural adaptive reaction to sublethal noxious stimuli. Although there is growing interest in advancing preconditioning to preserve brain function, preconditioning is not yet considered readily achievable in clinical settings. One of the most challenging issues is that there is no fine line between preconditioning stimuli and lethal stimuli. Here, we show deleterious effect of preconditioning on oligodendrocyte precursor cells (OPCs). We identified Bcl-2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3), a mitochondrial BH3-only protein specifically involved in OPCs loss after preconditioning. Repeated ischemia stabilized BNIP3 and increased the vulnerability of OPCs to subsequent ischemic events. BNIP3 became mitochondrial-bound and was concurrent with the dysfunction of monocarboxylate transporter 1 (MCT1). Inhibition of BNIP3 by RNAi or necrostatin-1 (Nec-1) and knocking out of BNIP3 almost completely prevented OPCs loss and preserved white matter integrity. Together, our results suggest that the unfavorable effect of BNIP3 on OPCs should be noted for safe development of ischemic tolerance. BNIP3 inhibition appears to be a complementary approach to improve the efficacy of preconditioning for ischemic stroke.
神经退行性病变可以受益于缺血预处理,这是一种对亚致死性有害刺激的自然适应反应。尽管人们越来越感兴趣地推进预处理以保护大脑功能,但预处理在临床环境中尚未被认为是容易实现的。最具挑战性的问题之一是,预处理刺激与致死性刺激之间没有明显的界限。在这里,我们展示了预处理对少突胶质前体细胞(OPC)的有害影响。我们鉴定了 Bcl-2/腺病毒 E1B 19kDa 相互作用蛋白 3(BNIP3),一种线粒体 BH3 仅蛋白,专门参与预处理后 OPC 的损失。反复的缺血稳定了 BNIP3,并增加了 OPC 对随后的缺血事件的脆弱性。BNIP3 成为线粒体结合蛋白,并与单羧酸转运蛋白 1(MCT1)的功能障碍同时发生。通过 RNAi 或坏死抑制剂-1(Nec-1)抑制 BNIP3 以及敲除 BNIP3 几乎完全防止了 OPC 的损失并保持了白质的完整性。总之,我们的结果表明,BNIP3 对 OPC 的不利影响在安全开发缺血耐受时应予以注意。BNIP3 抑制似乎是一种补充方法,可以提高预处理对缺血性中风的疗效。